JPMorgan lowered the firm’s price target on Inspire Medical (INSP) to $67 from $118 and keeps a Neutral rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target lowered to $85 from $130 at Mizuho
- Inspire Medical downgraded to Hold from Buy at Nephron Research
- Inspire Medical downgraded to Equal Weight from Overweight at Wells Fargo
- Inspire Medical downgraded to Neutral from Outperform at Baird
- Closing Bell Movers: Cisco falls 7% after earnings